Some health insurers are cracking down on off-label prescriptions of new weight loss drugs such as Ozempic, The Washington Post reported June 12.
The Latest
CMS' proposed rules to improve drug price transparency in Medicaid is a "positive step" toward controlling costs, Kate McEvoy, executive director of the National Association of Medicaid Directors, told Becker's.
A top Centene executive plans to retire next year, and the company is divesting its non-core businesses.
HHS Secretary Xavier Becerra is urging states to do more to prevent people from losing Medicaid coverage for procedural reasons.
North Carolina Gov. Roy Cooper signed a bill allowing Blue Cross Blue Shield of North Carolina to reorganize as a nonprofit holding company.
Providence Health Plan has named Lina Saadzoi as CFO and Timshel Tarbet as the company's first chief equity officer.
The Biden administration has reached a tentative deal that would preserve a provision of the ACA requiring insurers to cover preventive services while a Texas judge's ruling against the mandate is appealed in court.
From rolling back a planned gastroenterology endoscopy prior authorization policy to making an unsolicited cash offer to acquire Amedisys, here are 10 updates on UnitedHealth Group Becker's has reported since May 22.
New GLP-1 drugs to treat diabetes and obesity can be expensive, and most payers do not cover drugs only for weight loss for their members.
HHS has added 25 drugs to its list of products eligible for Inflation Reduction Act rebates.